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Introduction
Scedosporium species is an emergent fungal pathogen asso-
ciated with a wide range of infections ranging, from sub-
cutaneous mycetoma to disseminated sepsis [1]. Localized 
invasive lung infection with Scedosporium species, clini-
cally similar to that caused by Aspergillus spp., has been 
reported in patients with cavitory lung diseases [2, 3]. 
Treatment of Scedosporium infections is more challeng-
ing as it is highly resistant to commonly used antifungal 
agents especially amphotericin B [1]. Clinical outcome is 
frequently fatal (>80 %) especially for disseminated infec-
tions [4].
We are reporting here a case of localized lung sce-
dosporiosis in an immunocompetent host with clinical and 
radiological findings suggestive of aspergilloma. This case 
emphasizes the importance of considering Scedosporium 
spp in differential diagnosis of locally invasive lung infec-
tions and fungal balls. Culture should be requested for 
the resected specimen as it is difficult to differentiate 
Scedosporium from other filamentous molds on clinical 
grounds, microscopy, radiology and histopathology [2, 3].
Case
A 40-year-old man presented in pulmonology clinic with 
complaints of recurrent episodes of cough and hemopty-
sis for the last 4 years. He had a history of pulmonary TB 
15 years back. Physical examination revealed bronchial 
breathing in right upper and middle part of chest. Chest 
radiograph showed right-sided multiple thick walled cavi-
ties of different sizes. Multiple well-defined soft tissue den-
sity masses were present in at least two of these cavities. 
Computed tomography (CT) chest showed two thick-walled 
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cavities in right lung. The smaller one was in right upper 
lobe, (4.2 × 2.4 cm) with a fungal ball. The larger cav-
ity (10 × 4.5 cm) was in right lower lobe having a large 
fungal ball (47 × 29 mm), extending across major fissure 
to involve upper lobe as well. Both of these cavities were 
associated with surrounding bronchiectatic and fibrotic 
changes (Fig. 1). A diagnosis of multiple post-TB cavi-
ties with fungal ball (aspergilloma) was made. The patient 
underwent wedge resection of right upper lobe lesion. Tis-
sue was sent for histopathology and culture. Histopathol-
ogy revealed acute and chronic inflammation around the 
bronchioles, and hemorrhagic infarction; however, fun-
gal hyphae were not visualized. Similarly 10 % potas-
sium hydroxide smear of tissue was negative for fungal 
hyphae. Culture after 3 days of incubation on Sabouraud 
dextrose agar (SDA) yielded white, cottony colonies that 
later turned gray with a pale reverse (Fig. 2). The growth 
was seen on all inoculated plates. Microscopic examina-
tion showed septate hyaline hyphae with conidia 9 × 5 µm 
in diameter borne terminally, singly, or in small groups on 
elongated simple or branched conidiophores or laterally on 
hyphae. The conidia were ovoid, with the larger end toward 
the apex, and appeared to be cut off at the base, with a dis-
tinct brown wall (Fig. 2b). The growth was not inhibited 
by cycloheximide. On the basis of macroscopic and micro-
scopic features an identification of S. apiospermum was 
Fig. 1  Computed tomography scan of chest; arrow showing thick 
walled cavities with air-crescent sign
Fig. 2  a Left front; flat, floc-
cose colonies, a right reverse; 
pale yellow, b magnification 
×40, lactophenol cotton blue 
prepared slide from culture 
showing abundant oval conidia 
with scar at the base, larger end 
toward the apex, and appeared 
to be cut off at the base (arrow 
marked), c Voriconazole mini-
mum inhibitory concentration 
by E test
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made [5]. The minimum inhibitory concentration (MICs) 
by E test was >32 µg/ml for amphotericin B, >256 µg/ml 
for fluconazole, >32 µg/ml for itraconazole and 0.06 µg/ml 
for voriconazole (Fig. 2c). Histopathology even on deeper 
sections and fungal stains, including periodic acid Schiff 
and Gomori methenamine silver, did not reveal any fungal 
elements. Original sample was reprocessed for fungus cul-
ture and it once again grew the same organism.
The patient was started on voriconazole, first two doses 
of the drug were administered at 400 mg/12 h, and then the 
patient received maintenance doses of 200 mg/12 h (6 mg/
kg/day) for 4 months. Voriconazole plasma level could 
not be checked due to non-availability of diagnostic assay 
in Pakistan. He responded well to therapy. At 6-month 
follow-up he remained asymptomatic with chest X-ray 
improvement.
Discussion and the literature review
For the literature review we searched PubMed with the 
keywords “Pulmonary”, “Lung”, “Scedosporiosis”, “Sce-
dosporium”, “Pseudallescheria”, “boydii”, “prolificans”, 
“apiospermum” and “immunocompetent” in order to iden-
tify published cases of pulmonary scedosporiosis in an 
immunocompetent host. Seventeen cases were identified 
on PubMed (Table 1). Thus including current case, a total 
of 18 cases were analyzed for age and gender distribution, 
clinical symptoms and its duration, risk factor, treatment 
strategy and outcome. In case 6 no outcome was given. 
Therefore, case 6 was not analyzed in outcome analysis.
Gender and age analysis of cases (Table 1) showed male-
to-female ratio of 11:7 with mean age distribution 53 years 
(range 27–72 years). Cough was the most common pres-
entation (64 %) followed by hemoptysis (59 %) and fever 
(53 %). Duration of symptoms varied from acute presenta-
tion in near drowning cases to 10 years in patients with his-
tory of TB. Post-TB cavities (44.5 %, 8/18) were the most 
common risk factor to acquire pulmonary scedosporiosis. 
Surgery alone was used in 5/18 (28 %) and antifungal alone 
used in 7/18 (39 %). In 4/18 (22 %) cases, surgery along 
with antifungal therapy was used for treatment. Although 
overall case fatality rate was 35 % (6/17), 50 % (3/6) of 
cases that received antifungal therapy alone succumbed to 
death. All patients that underwent surgery alone were cured 
while 75 % (3/4) cases were responded well to combina-
tion of surgery and antifungal therapy. Two cases did not 
receive any therapeutic intervention and both expired.
This study emphasizes the importance of including Sce-
dosporium spp. in differential diagnosis of locally inva-
sive lung infections as clinical, histopathological and 
radiographic examinations were unable to differentiate Sce-
dosporium from other filamentous fungi like Aspergillus. 
This diagnostic confusion may delay the management of 
Scedosporium infection leading to poor outcomes. Castón 
et al. in a prospective cohort study found no difference 
between invasive pulmonary infection by Scedosporium 
apiospermum and invasive pulmonary aspergillosis on clini-
cal grounds. However, a significant association was seen 
with prophylactic use of amphotericin B and development of 
invasive pulmonary scedosporiosis [19]. This relative resist-
ance to amphotericin in Scedosporium spp. further highlights 
the significance of the definitive etiological characterization 
of Scedosporium through molecular diagnostics or culture.
Scrutinizing the cases regarding the gender distribu-
tion showed predominance of male (62.5 %) over female. 
Similarly in a review of 162 pulmonary and extra-pulmo-
nary scedosporiosis in both immunocompetent and immu-
nocompromised patients by Rodriguez-Tudela et al., there 
was a preponderance of infections in males by 63 % [8].
Post-TB cavity formation was the most common risk 
factor for acquiring the pulmonary infections in most of the 
reported cases. Another review of cases of pulmonary sce-
dosporiosis by Kantarcioglu et al. also highlights post-TB 
cavitation as a major risk factor [20]. As in our case study, 
high mortality rates with pulmonary scedosporiosis in 
immunocompetent patients have been reported in literature. 
Kantarcioglu et al. reported a mortality rate of 26.8 and 
57.2 % in patients with non-invasive and invasive infec-
tions, respectively [20].
On further review of the six cases with fatal outcome, 
two patients (Table 1; cases 7 and 9) did not receive any 
intervention, neither surgery nor antifungals. Three patients 
(Table 1; cases 8, 10 and 14) received antifungal therapy 
with ketoconazole, itraconazole and amphotericin B, 
respectively. The patient (Table 1; case 12) who received 
voriconazole for 1 month (dose not mentioned) deterio-
rated; lobectomy was performed but died within few hours 
of surgery. In cases with favorable outcome 8/11 (89 %) 
cases received surgical intervention and two of these 
patients (Table 1; cases 11 and 15) also received antifun-
gal treatment initially. However due to poor response, the 
lesion was surgically excised. Three patients had received 
only antifungal therapy and in two of these patients 
(Table 1; cases 5 and 16) voriconazole dose was adjusted 
by monitoring plasma drug levels. The third patient 
(Table 1; case 17) received miconazole for 10 weeks, but 
due to its side effects it was replaced with ketoconazole. 
Chen et al. reported a case of disseminated Scedosporium 
infection in a patient with history of near drowning. The 
infection was cured by medical treatment with voricona-
zole without any surgical intervention [17]. However, in 
an analysis of 107 patients Troke et al. reported success-
ful therapeutic response in only 57 % of patients with sce-
dosporiosis. In this study clinical outcome in pulmonary 
cases were not analyzed separately [7]. Rodriguez-Tudela 
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et al. showed that survival was independently associated 
with surgical excision [8]. Kantarcioglu et al. also reported 
that of 22/46 cases that survived underwent surgical exci-
sion as therapeutic intervention [20]. Outcome analysis in 
our study cases supports the surgical excision of the disease 
as a component of the standard of care.
In our case report, the isolated organism showed low 
MICs to voriconazole and high ones to fluconazole, itra-
conazole and amphotericin. Since no Clinical Laboratory 
Standards Institute breakpoints are available for suscepti-
bility interpretation for Scedosporium spp., we were unable 
to categorize the strain as susceptible or resistant. This sus-
ceptibility pattern is supported by various in vitro studies 
that showed that Scedosporium has low MICs against vori-
conazole and high MICs against amphotericin B, itracona-
zole, fluconazole, ketoconazole and echinocandins [6, 7].
There was discrepancy with histopathological report of 
the lesion: no fungal elements were revealed despite exam-
ining deep sections with fungal stains. It was discovered 
that a very small sized tissue was sent for histopathology 
and which could very likely be non-representative of the 
entire sample. This highlights the importance of sending 
appropriate quantity and quality of specimens sample for 
laboratory investigations. The likelihood of contamina-
tion of the specimen in the laboratory was eliminated by 
two means: growth of the same organism appeared on all 
culture plates and reprocessing of culture again yielded the 
same organism.
We were unable to confirm the identification of the iso-
late by DNA sequencing due to limited resources. How-
ever, Scedosporiuum apiospermum is one of the more com-
monly seen fungi in the clinical laboratory, its phenotypic 
identification by our laboratory can be relied upon as our 
laboratory regularly participates in external quality assur-
ance by College of American Pathologists and has consist-
ently shown satisfactory results.
Conclusion
Every fungal ball in preformed lung cavities is not an 
aspergilloma. Fungal cultures or molecular diagnostic tools 
are necessary for definite diagnosis and appropriate thera-
peutic measures.
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